<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: Drug Manufacturers - Other Industry News</title><link>http://biz.yahoo.com/ic/news/511.html</link><description>The latest news on the Drug Manufacturers - Other industry from Yahoo! Finance</description><language>en-us</language><lastBuildDate>Mon, 13 Oct 2008 20:30:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Endo Pharmaceuticals to Hold Conference Call and Webcast on Third Quarter 2008 Financial Results (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/081013/0442347.html</link><description></description><guid isPermaLink="false">yahoo_finance/2110033534</guid><pubDate>Mon, 13 Oct 2008 20:30:00 Etc/GMT</pubDate></item><item><title>Barr Pharma Deal Should Close (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/081013/15213.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/742273637</guid><pubDate>Mon, 13 Oct 2008 20:07:50 Etc/GMT</pubDate></item><item><title>NexMed Receives NASDAQ Listing Qualifications Letter (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081013/20081013005312.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/602862802</guid><pubDate>Mon, 13 Oct 2008 14:14:00 Etc/GMT</pubDate></item><item><title>Acusphere&apos;s Imagify(TM) to be Reviewed at FDA Advisory Committee Meeting on December 10, 2008 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081013/20081013005327.html?.v=1</link><description>WATERTOWN, Mass.----Acusphere, Inc. announced today that the Food and Drug Administration has published a Federal Register Notice on the FDA website of a planned public meeting of the Cardiovascular and Renal Drugs Advisory Committee on December 10, 2008.</description><guid isPermaLink="false">yahoo_finance/874589354</guid><pubDate>Mon, 13 Oct 2008 12:00:00 Etc/GMT</pubDate></item><item><title>Acura Pharmaceuticals and King Pharmaceuticals Announce Positive Top Line Results of Key Clinical Study Assessing Abuse Liability (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/081013/152026.html</link><description>PALATINE, Ill. and BRISTOL, Tenn., Oct. 13, 2008 -- Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. today announced top-line results from Study AP-ADF-111 entitled &quot;A Phase II, Single-Center, Randomized, Double-Blind, Assessment of the Abuse Liability of Acurox Tablets in Subjects with a History of Opioid Abuse.&quot;</description><guid isPermaLink="false">yahoo_finance/1297672832</guid><pubDate>Mon, 13 Oct 2008 12:00:00 Etc/GMT</pubDate></item><item><title>King extends tender offer for Alpharma (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/081013/king_alpharma_acquisition.html?.v=1</link><description>King Pharmaceuticals Inc. on Monday extended its tender offer for shares of Alpharma Inc. to Nov. 21 in an effort to complete its planned $1.6 billion buyout of the rival pain drug developer.</description><guid isPermaLink="false">yahoo_finance/2908142924</guid><pubDate>Mon, 13 Oct 2008 11:55:34 Etc/GMT</pubDate></item><item><title>King Pharmaceuticals extends tender offer for Alpharma (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11iiumket/*http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b8D284795-071B-439E-BB1D-74AF274F9885%7d&amp;siteid=yhoof2</link><description></description><guid isPermaLink="false">yahoo_finance/536293037</guid><pubDate>Mon, 13 Oct 2008 11:22:20 Etc/GMT</pubDate></item><item><title>Biodel Receives Notice of Allowance for Insulin Patent Claims in Europe (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081013/20081013005326.html?.v=1</link><description>DANBURY, Conn.----Biodel Inc. announced today that it has received a notice of allowance from the European Patent Office for patent claims covering compositions and uses of formulations of insulin for Biodel&apos;s two lead product candidates, VIAject and VIAtab, in the treatment of diabetes.</description><guid isPermaLink="false">yahoo_finance/409908367</guid><pubDate>Mon, 13 Oct 2008 11:00:00 Etc/GMT</pubDate></item><item><title>King Pharmaceuticals Extends Tender Offer to Acquire Alpharma (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081013/20081013005492.html?.v=1</link><description>BRISTOL, Tenn.----King Pharmaceuticals, Inc. today announced that it is extending its previously announced tender offer for all outstanding shares of Class A Common Stock of Alpharma Inc. until 5:00 pm, New York City time, on November 21, 2008, unless the offer is further extended.</description><guid isPermaLink="false">yahoo_finance/1863445765</guid><pubDate>Mon, 13 Oct 2008 11:00:00 Etc/GMT</pubDate></item><item><title>Dr. Reddy&apos;s to Release Q2 FY09 Results on October 23, 2008; Earnings Call Slated for October 23, 6.30 PM IST/9.00 AM EST (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081013/20081013005415.html?.v=1</link><description>HYDERABAD, India----Dr. Reddy&apos;s Laboratories will announce results for the Second Quarter ended September 30, 2008 on Thursday, October 23, 2008 after the Board Meeting. The results will be available on the Company&apos;s website www.drreddys.com.</description><guid isPermaLink="false">yahoo_finance/513682986</guid><pubDate>Mon, 13 Oct 2008 07:54:00 Etc/GMT</pubDate></item><item><title>Pharmaxis Investor Conference Call (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/081013/hkm002.html?.v=75</link><description>Pharmaxis Ltd will release its September 2008 Quarterly Report to Shareholders on the afternoon of Wednesday 15th October.</description><guid isPermaLink="false">yahoo_finance/2186107565</guid><pubDate>Mon, 13 Oct 2008 07:15:00 Etc/GMT</pubDate></item><item><title>AtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 Filing (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/081010/0442159.html</link><description></description><guid isPermaLink="false">yahoo_finance/2516317706</guid><pubDate>Fri, 10 Oct 2008 21:15:00 Etc/GMT</pubDate></item><item><title>Chattem to Webcast Presentation from Wachovia Consumer Growth Conference on October 14, 2008 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081010/20081010005595.html?.v=1</link><description>CHATTANOOGA, Tenn.----Bob Bosworth, President and Chief Operating Officer, of Chattem, Inc. , will present at the Wachovia Consumer Growth Conference on Tuesday, October 14, 2008 beginning at 1:00 p.m.</description><guid isPermaLink="false">yahoo_finance/3699841269</guid><pubDate>Fri, 10 Oct 2008 20:15:00 Etc/GMT</pubDate></item><item><title>Synvista Therapeutics Appoints William Federici to its Board of Directors (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/081010/ny38360.html?.v=1</link><description>Synvista Therapeutics, Inc. announces that it has appointed William Federici, 49, to its Board of Directors, expanding the board to five members.</description><guid isPermaLink="false">yahoo_finance/3803596700</guid><pubDate>Fri, 10 Oct 2008 20:07:00 Etc/GMT</pubDate></item><item><title>Biodel Announces Timing of FDA Discussions on VIAject(TM) (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081010/20081010005074.html?.v=1</link><description>DANBURY, Conn.----Biodel Inc. announced today that it will meet with officials from the U.S. Food and Drug Administration&apos;s Division of Metabolic and Endocrine Drug Products by the end of January 2009 to discuss the submission of a new drug application based on the results of two pivotal Phase III clinical trials of VIAject&amp;#8482; in patients with Type 1 and Type 2 diabetes.</description><guid isPermaLink="false">yahoo_finance/3868674007</guid><pubDate>Fri, 10 Oct 2008 11:00:00 Etc/GMT</pubDate></item><item><title>Santarus Commences GLUMETZA Promotion (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081010/20081010005069.html?.v=1</link><description>SAN DIEGO----Santarus, Inc. , a specialty pharmaceutical company, today announced that it has commenced promotion of GLUMETZA® , a once-daily, extended-release formulation of metformin that incorporates patented drug delivery technology and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.</description><guid isPermaLink="false">yahoo_finance/3228003465</guid><pubDate>Fri, 10 Oct 2008 08:00:00 Etc/GMT</pubDate></item><item><title>Shionogi Completes Acquisition of Sciele (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/081009/20081009005820.html?.v=1</link><description>OSAKA, Japan &amp; ATLANTA----On October 9, 2008, Shionogi &amp; Co., Ltd. and Sciele Pharma, Inc. announced the completion of Shionogi&apos;s acquisition of Sciele for US$31.00 per share in cash.</description><guid isPermaLink="false">yahoo_finance/2840290924</guid><pubDate>Thu, 9 Oct 2008 21:01:00 Etc/GMT</pubDate></item><item><title>King rises after analyst upgrades on lower risk (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/081009/king_pharmaceuticals_mover.html?.v=2</link><description>Shares of drug maker King Pharmaceuticals Inc. rose Thursday after a Natixis Bleichroeder analyst upgraded the stock, pointing to its &quot;astounding&quot; low levels.</description><guid isPermaLink="false">yahoo_finance/2344364092</guid><pubDate>Thu, 9 Oct 2008 19:43:31 Etc/GMT</pubDate></item><item><title>Vertex, Fallon working to get Fan Pier deal done, Menino says (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=126huh3te/*http://boston.bizjournals.com/boston/stories/2008/10/06/daily49.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/1630983361</guid><pubDate>Thu, 9 Oct 2008 19:25:18 Etc/GMT</pubDate></item><item><title>Biotech Stocks: Drug stocks see-saw into red in afternoon trading (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12k9qgru4/*http://www.marketwatch.com/news/story/drug-stocks-see-saw-red-afternoon/story.aspx?guid=%7B10D7C097%2DE202%2D4CA2%2D9A0B%2D403045805CEC%7D&amp;siteid=yhoof</link><description>Drug stocks see-saw with most of the large cap drugmakers trading in negative territory by mid-afternoon.</description><guid isPermaLink="false">yahoo_finance/3151877331</guid><pubDate>Thu, 9 Oct 2008 18:34:00 Etc/GMT</pubDate></item></channel></rss><!-- c44.finance.re4.yahoo.com uncompressed/chunked Mon Oct 13 16:04:01 PDT 2008 -->
